These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Iron homeostasis and tumorigenesis: molecular mechanisms and therapeutic opportunities. Zhang C; Zhang F Protein Cell; 2015 Feb; 6(2):88-100. PubMed ID: 25476483 [TBL] [Abstract][Full Text] [Related]
7. Crosstalk between miRNA and PI3K/AKT/mTOR signaling pathway in cancer. Akbarzadeh M; Mihanfar A; Akbarzadeh S; Yousefi B; Majidinia M Life Sci; 2021 Nov; 285():119984. PubMed ID: 34592229 [TBL] [Abstract][Full Text] [Related]
8. The emerging role of non-coding RNAs in the regulation of PI3K/AKT pathway in the carcinogenesis process. Ghafouri-Fard S; Abak A; Tondro Anamag F; Shoorei H; Majidpoor J; Taheri M Biomed Pharmacother; 2021 May; 137():111279. PubMed ID: 33493969 [TBL] [Abstract][Full Text] [Related]
9. FoxO transcription factors in cancer metabolism. Yadav RK; Chauhan AS; Zhuang L; Gan B Semin Cancer Biol; 2018 Jun; 50():65-76. PubMed ID: 29309929 [TBL] [Abstract][Full Text] [Related]
10. Identification of a novel muscle A-type lamin-interacting protein (MLIP). Ahmady E; Deeke SA; Rabaa S; Kouri L; Kenney L; Stewart AF; Burgon PG J Biol Chem; 2011 Jun; 286(22):19702-13. PubMed ID: 21498514 [TBL] [Abstract][Full Text] [Related]
11. [Nuclear EGFR: a new mode of oncogenic signalling in cancer]. Gazzeri S Biol Aujourdhui; 2018; 212(1-2):27-33. PubMed ID: 30362453 [TBL] [Abstract][Full Text] [Related]
12. Cancer cell metabolism connects epigenetic modifications to transcriptional regulation. Morrison AJ FEBS J; 2022 Mar; 289(5):1302-1314. PubMed ID: 34036737 [TBL] [Abstract][Full Text] [Related]
13. Biallelic truncating variants in the muscular A-type lamin-interacting protein (MLIP) gene cause myopathy with hyperCKemia. Salzer-Sheelo L; Fellner A; Orenstein N; Bazak L; Lev-El Halabi N; Daue M; Smirin-Yosef P; Van Hout CV; Fellig Y; Ruhrman-Shahar N; Staples J; Magal N; Shuldiner AR; Mitchell BD; Nevo Y; Pollin TI; Gonzaga-Jauregui C; Basel-Salmon L Eur J Neurol; 2022 Apr; 29(4):1174-1180. PubMed ID: 34935254 [TBL] [Abstract][Full Text] [Related]
14. Re-evaluating the role of FOXOs in cancer. Hornsveld M; Dansen TB; Derksen PW; Burgering BMT Semin Cancer Biol; 2018 Jun; 50():90-100. PubMed ID: 29175105 [TBL] [Abstract][Full Text] [Related]
15. Metabolic Reprogramming by the PI3K-Akt-mTOR Pathway in Cancer. Lien EC; Lyssiotis CA; Cantley LC Recent Results Cancer Res; 2016; 207():39-72. PubMed ID: 27557534 [TBL] [Abstract][Full Text] [Related]
16. The emerging roles of ARID1A in tumor suppression. Wu RC; Wang TL; Shih IeM Cancer Biol Ther; 2014 Jun; 15(6):655-64. PubMed ID: 24618703 [TBL] [Abstract][Full Text] [Related]
17. The Roles of the Let-7 Family of MicroRNAs in the Regulation of Cancer Stemness. Ma Y; Shen N; Wicha MS; Luo M Cells; 2021 Sep; 10(9):. PubMed ID: 34572067 [TBL] [Abstract][Full Text] [Related]
18. FOXO family in regulating cancer and metabolism. Ma J; Matkar S; He X; Hua X Semin Cancer Biol; 2018 Jun; 50():32-41. PubMed ID: 29410116 [TBL] [Abstract][Full Text] [Related]
19. The scaffold protein disabled 2 (DAB2) and its role in tumor development and progression. Pandya DV; Parikh RV; Gena RM; Kothari NR; Parekh PS; Chorawala MR; Jani MA; Yadav MR; Shah PA Mol Biol Rep; 2024 Jun; 51(1):701. PubMed ID: 38822973 [TBL] [Abstract][Full Text] [Related]
20. Homeostasis and the importance for a balance between AKT/mTOR activity and intracellular signaling. Altomare DA; Khaled AR Curr Med Chem; 2012; 19(22):3748-62. PubMed ID: 22680924 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]